Patient Advocacy in Vascularized Composite Allotransplantation.
作者信息
Benedict James
机构信息
Center for Global Health Ethics, Duquesne University, Pittsburgh, PA, United States.
出版信息
Front Psychol. 2022 Jul 18;13:943393. doi: 10.3389/fpsyg.2022.943393. eCollection 2022.
Abstract
摘要
相似文献
1
Patient Advocacy in Vascularized Composite Allotransplantation.血管化复合组织异体移植中的患者权益维护
Front Psychol. 2022 Jul 18;13:943393. doi: 10.3389/fpsyg.2022.943393. eCollection 2022.
2
Perioperative risk factors for vascularized composite allotransplantation: a systematic review and proposal of identity-defining VCA.血管化复合组织同种异体移植的围手术期风险因素：系统评价和定义身份的 VCA 提案。
Microsurgery. 2014 Mar;34(3):240-4. doi: 10.1002/micr.22125. Epub 2013 Jul 9.
3
Current concepts and systematic review of vascularized composite allotransplantation of the abdominal wall.腹壁血管化复合组织同种异体移植的当前概念和系统评价。
Clin Transplant. 2013 Nov-Dec;27(6):781-9. doi: 10.1111/ctr.12243. Epub 2013 Sep 16.
4
The Advent of Vascularized Composite Allotransplantation.血管化复合组织异体移植的出现。
Clin Plast Surg. 2017 Apr;44(2):425-429. doi: 10.1016/j.cps.2016.12.007. Epub 2017 Feb 3.
5
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.血管化复合组织异体移植中慢性排斥反应的定义——美国重建移植学会和国际血管化复合组织异体移植学会慢性排斥反应工作组：2018年美国重建移植学会会议报告及白皮书 血管化复合组织异体移植中慢性排斥反应定义的研究目标
SAGE Open Med. 2020 Jul 14;8:2050312120940421. doi: 10.1177/2050312120940421. eCollection 2020.
6
Vascularized composite tissue allotransplantation--state of the art.血管化复合组织同种异体移植——最新技术。
Clin Transplant. 2013 May-Jun;27(3):330-7. doi: 10.1111/ctr.12117. Epub 2013 Apr 14.
7
8
Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?血管化复合组织移植中的免疫抑制维持：何为恰到好处？
Curr Opin Organ Transplant. 2017 Oct;22(5):463-469. doi: 10.1097/MOT.0000000000000456.
9
Split rejection in vascularized composite allotransplantation.血管化复合组织异体移植中的分裂性排斥反应。
Eplasty. 2013 Oct 8;13:e53.
10
Evolving ethics, policy and reimbursement issues of vascularized composite allotransplantation: Symposium summary.血管化复合组织异体移植不断演变的伦理、政策和报销问题：研讨会总结
SAGE Open Med. 2019 Jul 26;7:2050312119866944. doi: 10.1177/2050312119866944. eCollection 2019.
引用本文的文献
1
Patient definitions of transplant success in upper extremity vascularized composite allotransplantation: A mixed-methods study.上肢血管化复合组织异体移植中患者对移植成功的定义：一项混合方法研究。
SAGE Open Med. 2023 Jul 13;11:20503121231184677. doi: 10.1177/20503121231184677. eCollection 2023.
2
Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantation: A scoping review and viewpoint of recent developments and clinical experiences in the field of vascularized composite allotransplantation.血管化复合组织异体移植未来面临的社会心理和生物伦理挑战与发展：血管化复合组织异体移植领域近期发展及临床经验的范围综述与观点
Front Psychol. 2022 Dec 15;13:1045144. doi: 10.3389/fpsyg.2022.1045144. eCollection 2022.
本文引用的文献
1
Ethics of Advocacy.倡导的伦理
R I Med J (2013). 2022 Apr 1;105(3):13-16.
2
Perspectives, Expectations, and Concerns of European Patient Advocates on Advanced Therapy Medicinal Products.欧洲患者权益倡导者对先进治疗药品的观点、期望与担忧
Front Med (Lausanne). 2021 Nov 23;8:728529. doi: 10.3389/fmed.2021.728529. eCollection 2021.
3
Ethical Challenges in Independent Living Donor Advocacy.独立生活供者倡导中的伦理挑战
Prog Transplant. 2021 Sep;31(3):242-248. doi: 10.1177/15269248211024600. Epub 2021 Jun 23.
4
Perspectives of 281 patients with Mayer-Rokitansky-Küster-Hauser Syndrome on uterine transplantation.281 例 Mayer-Rokitansky-Küster-Hauser 综合征患者对子宫移植的看法。
Fertil Steril. 2021 Apr;115(4):1074-1083. doi: 10.1016/j.fertnstert.2020.10.044. Epub 2021 Jan 16.
5
Patient advocacy in nursing: A concept analysis.护理中的患者倡导：概念分析。
Nurs Ethics. 2020 Feb;27(1):141-151. doi: 10.1177/0969733019832950. Epub 2019 May 20.
6
Emerging Ethical Challenges Raised by the Evolution of Vascularized Composite Allotransplantation.血管化复合组织异体移植演进引发的新兴伦理挑战。
Transplantation. 2019 Jun;103(6):1240-1246. doi: 10.1097/TP.0000000000002478.
7
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.促进癌症研究中的科学家-倡导者合作：为什么以及如何。
Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17.
8
Outcomes after hand and upper extremity transplantation.手部及上肢移植后的结果。
J Mater Sci Mater Med. 2017 May;28(5):72. doi: 10.1007/s10856-017-5880-0. Epub 2017 Mar 30.
9
The concept of 'vulnerability' in research ethics: an in-depth analysis of policies and guidelines.研究伦理中的“脆弱性”概念：对政策与指南的深入分析
Health Res Policy Syst. 2017 Feb 7;15(1):8. doi: 10.1186/s12961-016-0164-6.
10
Physician assisted suicide and clinical vulnerability: a slippery slope.医生协助自杀与临床脆弱性：一个滑坡谬误。
Clin Ter. 2016 Sep-Oct;167(5):e92-e95. doi: 10.7417/CT.2016.1950.
Zotero 插件